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Ataxin-3  is the  protein  responsible  for  the  neurodegenerative  polyglutamine  disease  Spinocerebellar
ataxia  type  3.  Full  structural  characterisation  of  ataxin-3  is required  to  aid  in  understanding  the  mech-
anism  of  disease.  Despite  extensive  study,  little  is  known  about  the conformational  properties  of  the
full-length  protein,  in  either  its non-expanded  healthy  or expanded  pathogenic  forms,  particularly  since
its polyglutamine-containing  region  has  denied  structural  elucidation.  In this  work,  travelling-wave  ion
mobility  spectrometry–mass  spectrometry  and  limited  proteolysis  have  been  used  to  compare  the  con-
formational  properties  of  full-length  non-expanded  ataxin-3  (14Q)  and  its  isolated  N-terminal  Josephin
domain  (JD).  Limited  proteolysis  experiments  have  conﬁrmed  that  the  JD  is stable,  being  extremely
resistant  to trypsin  digestion,  with  the  exception  of  the  2/3 hairpin  which  is ﬂexible  and  exposed
to  protease  cleavage  in  solution.  The  C-terminal  region  of  ataxin-3  which  contains  the  glutamine-richlectrospray ionisation-mass spectrometry sequences  is  largely  unstructured,  showing  little  resistance  to limited  proteolysis.  Using  ion  mobility
spectrometry–mass  spectrometry  we  show  that  ataxin-3  (14Q)  adopts  a wide  range  of  conformational
states  in  vitro  conferred  by  the  ﬂexibility  of  its C-terminal  tail  and  the  2/3 hairpin  of the  N-terminal
JD. This  study  highlights  how  the  power  of  MS-based  approaches  to  protein  structural  characterisation
can  be particularly  useful  when  the target  protein  is  aggregation-prone  and  has  intrinsically  unordered
regions.
. Introduction
.1. Mass spectrometry as a structural biology tool
Over the last 20 years, mass spectrometry (MS) analysis
f biological molecules has become an important component
f the structural biology toolbox. With the advent of electro-
pray ionisation (ESI), the ability to ionise and analyse large
iological molecules was soon realised and the use of MS  in bio-
ogical applications has become a powerful method of protein
tructure elucidation, especially for large and complex sam-
les [1,2]. MS  analyses beneﬁt from being extremely rapid and
aving high sensitivity, requiring only picomolar amounts of
ample.
Non-covalent MS  analyses, where experiments are conducted
nder carefully controlled solvent and instrumental conditions, can
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be used to yield information about a protein or protein complex
that reﬂects its behaviour in solution. Consequently, non-covalent
MS has been used to mass measure protein complexes ≤10 MDa
[3–5] and to deduce their stoichiometry, topological arrangements
and dynamics [6–10]. When ESI-MS analysis is coupled with ion
mobility spectrometry (IMS) information on analyte shape, includ-
ing the separation and size determination of co-populated protein
conformers, as well as insights into the quaternary structure of
macromolecular assemblies, can be gained simultaneously with
mass measurements [11–18]. ESI-IMS–MS is particularly useful for
the study of heterogeneous samples as it can separate and subse-
quently identify individual components within a mixture in a single
experiment. It can also be used to track biomolecular reactions,
yielding information about kinetic intermediates even when these
are transient and/or lowly populated [17,19]. Such analyses are of
prime importance when NMR  spectroscopy or X-ray analysis of the
biomolecule, or biomolecular complex, in question is unfeasible or
extremely difﬁcult.Here, ESI-IMS–MS in conjunction with limited proteolysis
studies have been used to provide insights into the structure
and dynamics of ataxin-3, a clinically important polyglutamine-
containing protein.
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Fig. 1. Schematic diagrams of (a) the Josephin domain (JD), and (b) ataxin-3 (14Q).
The cartoons illustrate the relative positions of the JD, the ubiquitin interacting4 C.A. Scarff et al. / International Journal 
.2. Ataxin-3 and polyglutamine disease
Ataxin-3 is the protein associated with the neurodegenerative
olyglutamine (polyQ) disease spinocerebellar ataxia type 3 or
achado–Joseph disease [20–23]. PolyQ diseases are a group of
nherited neurodegenerative disorders, characterised by the accu-
ulation of polyQ-containing neuronal aggregates in particular
egions of the brain, whose causative agents are proteins with
xpanded polyQ stretches [24,25]. These polyQ-expanded proteins
re a result of unstable expansion of CAG trinucleotide repeats in
heir respective gene products, with expansion beyond a particu-
ar length, usually >50 contiguous Q residues, resulting in disease
22,26].
An inverse correlation between the number of CAG repeats and
he age of onset of disease has been observed for all the polyQ
isorders and so polyQ aggregation and polyQ-directed protein
isfolding are thought to play key roles in pathogenesis [22,27].
espite these uniting features of polyQ disease, polyQ proteins
how no sequence homology, except in their polyQ tracts, exhibit
ifferent functions, result in different pathognomonic symptoms
nd neurodegenerative proﬁles, and affect different regions of the
rain [22,25,27].
A detailed understanding of the mechanisms by which expres-
ion of polyQ-expanded proteins leads to pathology is required in
rder to generate therapeutic approaches against these disorders
25]. Characterisation of polyQ-containing protein structure, mis-
olding and aggregation states is an essential component of such
tudies. PolyQ-containing proteins, however, are particularly chal-
enging to study as they are often structurally dynamic, contain
ntrinsically disordered regions and are aggregation-prone [22,28].
MS–MS is therefore an ideal tool for the study of such systems yet,
o date, has not been applied rigorously to the structural character-
sation of this important set of disease-causing proteins.
.3. Ataxin-3 structure
Ataxin-3 is a 42–52 kDa protein that contains an N-terminal
osephin domain (JD; residues 1–182) followed by two  ubiquitin
nteracting motifs (UIMs), a polyQ stretch of variable length, and
 variable C-terminal region [29]. The polyQ stretch consists of
2–44 glutamine residues in healthy individuals and results in dis-
ase when expanded beyond approximately 54 glutamine residues
30]. In one of the known isoforms of this protein, the predomi-
ant isoform in the brain, the C-terminal region includes a third
IM following the polyQ stretch (Fig. 1) [31]. Although the tertiary
tructure of the JD has been determined by use of solution NMR
pectroscopy [29,32,33], little is known about the conformational
roperties of the full-length ataxin-3 protein, with its C-terminal
egion herein termed the “tail” [26].
The NMR  structure of the JD revealed that this region consists
f two sub-domains: a relatively rigid globular catalytic domain
nd a ﬂexible 2/3  helical hairpin, the latter which exhibits fast
ocal motions and behaves much as an exposed “waving hand”
29,32–34]. In contrast, the tertiary structure of full-length ataxin-3
as so far evaded detailed structural characterisation at the atomic
evel. Previous NMR  and CD studies on ataxin-3 have suggested that
he C-terminal region of ataxin-3 has no deﬁned tertiary structure,
et has multiple secondary structural elements [32]. In addition,
MR  data have indicated that the overall fold of the JD is not per-
urbed by the presence of the C-terminal region of ataxin-3 and that
here are no signiﬁcant interactions between the two  regions [32].
To date, there has been a paucity of non-covalent MS  exper-
ments on polyQ-containing proteins, including ataxin-3. Indeed,
 single ESI-MS study comparing the conformational properties in
he presence of organic solvents or heat of the isolated JD with those
f a construct of ataxin-3 containing the JD and the adjacent ﬂexiblemotifs (UIMs) and the polyQ stretch (Q14). The NMR  structure for the isolated JD
(PDB 1YZB [29]) with the ﬂexible 2/3 hairpin is highlighted as a ribbon diagram
in  (a).
region (183–291) prior to the polyQ stretch has been reported [35],
with the authors concluding that the two constructs showed a sim-
ilar stability to denaturation. Here, by the use of limited proteolysis
and ESI-IMS–MS experiments we provide insights into the confor-
mational properties of the non-expanded ataxin-3 (14Q), which
contains a stretch of thirteen glutamine residues interrupted by a
lysine residue after the ﬁrst three glutamines, with a single glu-
tamine some six residues later, and by convention is named 14Q,
in comparison to the isolated JD. The results provide further evi-
dence that the tail of non-expanded ataxin-3 does not contain
deﬁned tertiary structure nor does it interact with the JD. This
work demonstrates the power of MS-based approaches to studying
polyQ-containing proteins and proteins with intrinsically disor-
dered regions.
2. Materials and methods
2.1. Protein expression and puriﬁcation
The cDNAs for human ataxin-3 (14Q) (isoform 2) and the JD
(ataxin-3 residues 1–182) were sub-cloned into pDEST17 plasmid
vectors [36]. Upstream of the coding site, a sequence coding for
an N-terminal hexahistidine tag and a linker region containing a
cleavage site for the recombinant tobacco etch virus (rTEV) protease
were incorporated. The proteins were expressed in the E. coli strain
BL21(DE3)-pLysS and puriﬁed by nickel-afﬁnity chromatography
followed by histidine-tag cleavage with a hexahistidine-tagged
rTEV protease [37]. Cleaved recombinant protein was  separated
from rTEV protease by nickel-afﬁnity chromatography and ataxin-
3 (14Q) and JD were then puriﬁed to homogeneity by gel-ﬁltration
chromatography using a Superdex S200 column. Each recombinant
protein construct retains one additional glycine residue at the N-
terminus due to the site of rTEV protease cleavage. Herein, this
residue is thus numbered zero in the amino acid sequence to avoid
confusion.
2.2. Sample preparation for MS
Protein samples were buffer exchanged into 10 mM  ammonium
acetate by use of ZEBA desalting columns (Thermo Fisher Scientiﬁc,
Loughborough, Leicestershire, UK) and prepared at a concentra-
tion of 10–20 M in 10 mM ammonium acetate for MS  analysis.
To perform limited proteolysis experiments, bovine trypsin (Sigma
Aldrich, Gillingham, Dorset, UK) was  added to each protein solution
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n a 1:100 molar ratio and incubated at 37 ◦C for different time
eriods.
.3. ESI-(IMS)–MS analysis
A Synapt HDMS quadrupole time-of-ﬂight mass spectrometer
Micromass UK Ltd., Waters Corpn., Manchester, UK) was  used to
nalyse the JD, ataxin-3 (14Q) and limited proteolysis samples.
amples were introduced into the instrument by direct infusion
anoESI with in-house prepared gold-coated borosilicate glass
apillaries. MS  and IMS–MS spectra were recorded in nanoESI posi-
ive mode using the following instrument parameters: cone voltage
0 V; source temperature 60 ◦C; backing pressure 3.5 mbar; trav-
lling wave height 9 V; travelling wave speed 350 m/s; IMS  gas
ow 20 mL/min. Data were processed by use of MassLynx v4.1
nd Driftscope software supplied with the mass spectrometer. Esti-
ated collision cross-sectional areas for different species were
alculated by use of a non-covalent protein calibration of beta-
actoglobulin, avidin and concanavalin A, following the protocol
escribed by Bush et al. [12]. Tryptic peptides resulting from limited
roteolysis of the JD and ataxin-3 (14Q) were separated by IMS  and
urther characterised by collision induced dissociation (CID) MS/MS
equencing when required.
.4. Modelling
Model structures were generated in PyMOL (DeLano Scientiﬁc,
an Carlos, CA, USA) by use of PDB structure 1YZB [29] as a starting
emplate. Theoretical collision cross-sectional areas for PDB 1YZB
nd model structures were calculated by use of the MOBCAL algo-
ithm projection approximation [38] corrected for protein shape
sing the linear ﬁt to the projected superposition approximation
PSA) [39]. This approximation has been shown to be a better
stimate of cross-section than the projection approximation as it
akes into account the convex-ness or concave-ness of a protein
tructure [39].
Fig. 2. ESI-MS spectra of (a) the isolated Josephin domain (JD) and (b) ataxin-3 (14Q).s Spectrometry 345– 347 (2013) 63– 70 65
3. Results and discussion
3.1. Non-covalent ESI-IMS–MS of the JD and ataxin-3
The extent of protein ionisation during the ESI process is cor-
related directly with the surface-exposed area and mass of the
protein [40]. The lowest charge states detected within the m/z
spectrum for a protein are most reﬂective of the native struc-
ture of that protein, whilst partially folded protein conformations
exhibit intermediate charge states and denatured or unfolded pro-
teins carry the highest number of charges. In the case of the JD,
the expected average charge states, based on mass [40], under
native conditions and denaturing conditions are 9+ and 22+, respec-
tively. For ataxin-3 (14Q) these are 14+ and 36+. The ESI-MS
spectra obtained for the isolated JD (measured mass 21,092.8 Da;
calculated mass 21,093.0 Da) and ataxin-3 (14Q) (measured mass
41,309.0 Da; calculated mass 41,307.2 Da) are shown in Fig. 2. One
narrow charge state distribution, corresponding to monomeric 6+
to 10+ charge state ions, was  populated predominantly in the
spectrum of the JD whereas a much broader range of charge
states was  observed in the spectrum of ataxin-3 (14Q). Both
spectra were acquired under identical experimental conditions
and comparison of the two  spectra thus indicates that the JD
adopts mainly a single, compact conformation whereas full-length
ataxin-3 (14Q) adopts multiple conformations, some more com-
pact (11+ to 15+) and others more extended (18+ to 38+). The
observation of such a wide array of charge states for a protein
analysed under native-like solvent conditions, as observed for
ataxin-3 (14Q), is unusual but is typical for intrinsically disor-
dered and semi-disordered proteins [41,42]. A second, very minor,
charge state distribution (10+ to 17+) was also observed in the
JD spectrum indicating the low population of a partially unfolded
state (Fig. 2a, inset). It is interesting to note that a population of
ions corresponding to a dimeric species was  also observed in the
spectrum of ataxin-3 (14Q). These were either not observed, or
were only very weakly populated, in the spectrum of the isolated
JD.
 Insets show the expanded (8×) region m/z 1000–2500. M,  monomer; D,  dimer.
66 C.A. Scarff et al. / International Journal of Mass Spectrometry 345– 347 (2013) 63– 70
Fig. 3. ESI-IMS–MS data for the JD and ataxin-3 (14Q). (a) Extracted arrival time distributions (ATDs) for the most abundant charge states observed within ESI-IMS–MS
spectra for the JD (8+) (upper) and ataxin-3 (14Q) (12+) (lower). Estimated cross-sections for each of the main peaks observed in the ATDs, corresponding to maxima drift
time  values and their approximate dispersion values (based on peak width at half-height), are indicated (b). Schematic of PDB structure 1YZB (black) and modelled structure
with  2/3 hairpin swung out (grey) overlaid; the calculated collision cross-sectional areas for these structures are 1959 and 2098 A˚2, respectively. (c) ESI-IMS–MS estimated
collision cross-sectional areas for all charge states observed for the isolated JD and ataxin-3 (14Q) (black diamond = JD, white triangle = ataxin-3 (14Q)). The size of symbols
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orizontal dotted lines; PSA, projected superposition approximation [39]. Schemat
ESI-IMS–MS experiments on ataxin-3 (14Q) support the notion
hat this protein adopts a range of compact and partially com-
act conformations that are co-populated in solution. Extracted
rrival time distributions (ATDs) for the dominant charge states
bserved (in each case the maximum of the lowest charge state
istribution which most reﬂects the native structure) for both the
D (8+) and ataxin-3 (14Q) (12+) exhibited multiple peaks over a
ange of drift times (Fig. 3a). Two main peaks (one with a shoul-
er) were observed in the extracted ATD for the dominant charge
tate of the JD with drift times of 6.16 and 9.23 ms (peak maxima
alues), from which collision cross-sectional areas of 1959 ± 35 A˚2
nd 2167 ± 66 A˚2, respectively, were estimated (Fig. 3a). These
bservations indicated the presence of at least two conformational
amilies of the JD, differing in collision cross-sectional area by
pproximately 10%. The collision cross-sectional area calculated
or the smaller of these two peaks is consistent with the theo-
etical value for the PDB structure 1YZB (1959 A˚2). The collision
ross-sectional area calculated for the second, more intense peak
ithin the ATD is comparable with that which may  be expected for
he JD with its 2/3  hairpin swung out (2098 A˚2), as modelled in
ig. 3b. The 2/3  hairpin of the JD domain is known to be solvent
xposed and ﬂexible in solution and to behave as an exposed “wav-
ng hand”, exhibiting fast local motions [29], and the ESI-IMS–MS
esults presented here are entirely consistent with this conclu-
ion. In comparison, the broader array of conformations sampled
y ataxin-3 (14Q) for the 12+ charge state ions differed in collision
ross-sectional area by up to 20% (3077 ± 56 A˚2, 3395 ± 156 A˚2, and
673 ± 75 A˚2), Fig. 3a. The additional variation in conformational
ize exhibited by ataxin-3 (14Q) is likely to correspond to addi-
ional conformations adopted through movement and ﬂexibility
ithin the “tail”.
Ataxin-3 (14Q) species with estimated collision cross-sectional
reas corresponding to a compact model where the protein exhibits
 globular conformation (Fig. 3c and d), were observed for theeoretical calculations of cross-sectional areas from model structures are shown as
strating (d) a compact model and (e) an expanded model of ataxin-3 (14Q).
lowest charge states populated, which are most reﬂective of
solution-phase structures. For higher charge states, representative
of more expanded conformers, signiﬁcantly larger collision cross-
sectional areas were estimated from ion mobility measurements.
Theoretical cross-sections for a fully extended model of the JD, with
its amino acids extended in a linear string, and for ataxin-3 (14Q)
with a folded JD but a fully extended C-terminal region (Fig. 3e),
are shown in Fig. 3c to illustrate the relative range of cross-sections
adopted.
The extent that the ESI-IMS–MS estimated collision cross-
sectional areas for the partially folded conformers for the JD and
ataxin-3 (14Q) mirror the conformeric populations in solution
is debatable. Gas-phase unfolding is driven by Coulombic repul-
sion forces. At low charge states, the effect of Coulomb repulsion
between charges is negligible and attractive-folding forces, such as
electrostatic interactions which are heightened in the gas phase,
dominate [43,44]. Thus, the lowest charge states observed are
most reﬂective of solution-phase structures. As the charge states
increase, the effect of Coulomb repulsion becomes more dominant
until at the highest charge states the increased Coulombic repulsion
between charges forces the protein to adopt more open conforma-
tions [44]. Various intermediate conformations may  form due to
the interplay between attractive-folding and repulsive-Coulombic
interactions [45]. For intrinsically disordered proteins, a scaling of
overall size as a function of the net charge per residue has been
observed [46].
Therefore, whilst some of the estimated collision cross-sectional
areas are likely reﬂective of partially folded solution-phase struc-
tures (e.g., charge states 11+ to 15+ for the JD and charge states
16+ to 24+ for ataxin-3 (14Q), where the presence of multiple con-
formations indicates some degree of structure) the most expanded
conformations may  be a result of unfolding in the electrospray pro-
cess due to Coulombic repulsion (charge states 16+ and 17+ for the
JD and charge states > 25+ for ataxin-3 (14Q), where single protein
C.A. Scarff et al. / International Journal of Mass Spectrometry 345– 347 (2013) 63– 70 67
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seen for the JD alone (Figs. 4, 5 and Table 1). In addition, tryptic
peptides consisting of residues 0–190, 48–190, and 60–190 were
observed, resulting from cleavage at Lys190 (Tables 1, 2 and Fig. 5b).
Table 1
Major products resulting from the limited proteolysis of the Josephin domain (JD)
and  ataxin-3 (14Q). In each case, ESI-MS spectra were acquired following the incu-
bation of 10 M protein with 0.1 M trypsin in 10 mM ammonium acetate, pH 7.4,
at  37 ◦C for 15 min.
Major products of limited proteolysis (amino acid residues)
Josephin domain Ataxin-3 (14Q)
60–182 60–182
–  60–190
0–182 0–182
–  0–190ig. 4. ESI-MS spectra showing the major products of limited proteolysis for (a) the
f  10 M protein with 0.1 M trypsin in 10 mM ammonium acetate, pH 7.4, at 37 ◦C
onformations are observed exhibiting a uniform increase in cross-
ectional area with increase in charge). It is clear, however, from the
omparison between the spectra and collision cross-sectional area
SI-IMS–MS estimates for the JD and ataxin-3 (14Q) that ataxin-3
14Q) adopts much more open conformations than the JD, strongly
uggesting that the tail region of ataxin-3 is much less ordered than
he JD as it is less restrained in the gas phase.
.2. Limited proteolysis of the JD and ataxin-3
Both the JD and ataxin-3 (14Q) were subjected to limited proteo-
ysis using the enzyme bovine trypsin to determine which regions
f these proteins are accessible to this protease. Limited proteoly-
is is a powerful tool that can be used to gain additional structural
nformation regarding a protein’s solvent-exposed regions or its
omain organisation. ESI-MS spectra obtained following the lim-
ted proteolysis of the JD and ataxin-3 (14Q) showed that many
f the major products of limited proteolysis are the same for the
orresponding regions of both species (Fig. 4). The major prod-
cts of limited proteolysis observed for the JD are highlighted in
ig. 5a, and a comparison of the products obtained for the JD and
he corresponding region of ataxin-3 (14Q) is presented in Table 1.
The key products observed following limited proteolysis of
he JD resulted from cleavage of sites within the 2/3  hairpin
-helices two and three cover residues 31–47 and 56–62, respec-
ively) at amino acids Arg47 and Arg59. These two cleavage sites are
nown to be exposed in solution [29] and so proteolysis here was
ot unexpected. Nonetheless, the unique identiﬁcation of these two
esidues as the most exposed sites to trypsin cleavage highlights the
ower of limited proteolysis to determine conformational proper-
ies of a target protein. The core of the JD (residues 60–182) wasd (b) ataxin-3 (14Q). In each case, spectra were acquired following the incubation
5 min. The protein sequences identiﬁed are indicated on the spectra.
found to be highly resistant to proteolysis and was still present
intact, even after 90 min  of exposure to trypsin (data not shown).
Interestingly, the experimental conditions were sufﬁciently gentle
that a species corresponding to the 0–47 residue fragment coupled
with the 60–182 residue fragment of the JD were observed in the
spectra as a non-covalently bound complex; trypsin had cleaved the
protein at residues 47 and 59 but the products of cleavage had not
dissociated. The individual peptides produced by cleavage, 0–47,
0–59 and 48–59 were also observed (Fig. 4).
In limited proteolysis studies of ataxin-3 (14Q), the N-terminal
region (residues 0–182) was found to undergo digestion at a sim-
ilar rate to the isolated JD and produced the same products as0–47 and 60–182 0–47 and 60–182
–  60–251
48–182 48–182
–  48–190
68 C.A. Scarff et al. / International Journal of Mass Spectrometry 345– 347 (2013) 63– 70
Fig. 5. Limited proteolysis of the isolated JD and ataxin-3 (14Q) following incubation of 10 M protein with 0.1 M trypsin in 10 mM ammonium acetate, pH 7.4, at 37 ◦C
for  15 min. The major products of limited proteolysis of the JD domain (0–182, 60–182, 48–182, 0–47 + 60–182) are highlighted in (a) on JD structures in the form of ribbon
diagrams, taken from the NMR structure for the isolated JD (PDB 1YZB [29]); these products resulted from cleavage at Arg47 and Arg59, both within the 2/3 hairpin. The
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dmino  acid sequence for ataxin-3 (14Q) is shown in (b) with the major products of
omain  (0–182) is highlighted in grey. The trypsin cleavage sites (orange bars) high
nterpretation of the references to colour in this ﬁgure legend, the reader is referred
he observation of these products indicates that Arg182 (the ﬁnal
esidue of the JD within the ataxin-3 (14Q) sequence) is buried, to
ome extent, within the tertiary structure of ataxin-3 (14Q), limit-
ng access of trypsin to this cleavage site. This is consistent with
ork by Masino et al. on a similar construct, where equivalent
leavage products were observed for ataxin-3 (14Q) but the isolated
able 2
imited proteolysis cleavage products of the C-terminal region of ataxin-3 (14Q)
igested with 0.01 (molar ratio concentration) bovine trypsin for 15 min  at 37 ◦C.
Trypsin cleavage site
(residue number)
Cleavage product
observed
Mass-to-charge ratios of
cleavage products observed
190 183–190 1023.6 (1+), 512.28 (2+)
200  191–200 557.3 (2+)
203 191–203 763.9 (2+)
206 191–206 946.0 (2+), 631.0 (3+)
211 204–211 997.5 (1+)
231 212–231 1118.0 (2+), 745.7 (3+)
237 232–237 630.4 (1+)
250 232–250 1102.5 (2+)
251 238–251 874.9 (2+)
262 252–262 1177.6 (1+), 589.3 (2+)
282 263–282 1113.0 (2+), 742.4 (3+)
283 263–283 1177.0 (2+)
284 263–284 837.0 (3+)
291 286–291 786.4 (1+)
295 286–295 649.8 (2+)
295 292–295 531.3 (1+)
352 353–361 1032.6 (1+)
356 357–361 562.3 (1+)
360 – –d proteolysis (0–182, 60–182, 48–182, 0–47 + 60–182, 0–190 and 48–190). The JD
d within the tail region (residues 183–361) all showed evidence of proteolysis. (For
e web version of the article.)
JD was not analysed for comparison in that study [26,32]. The gener-
ation of the same JD cleavage products in approximately the same
intensities upon limited proteolysis of the JD and ataxin-3 (14Q)
indicate that there are little or no differences in the accessibility of
these cleavage sites in the absence or presence of the C-terminal
“tail”. This suggests that the C-terminal region of ataxin-3 (14Q)
does not interact with the JD in any signiﬁcant manner, at least to
the extent that the accessibility of Lys or Arg residues within the JD
to trypsin cleavage is altered signiﬁcantly.
Dimeric species of the product 60–182 were observed in the
ESI mass spectra following limited proteolysis of both the JD and
ataxin-3 (14Q), suggesting that the dimerisation domain of ataxin-3
(14Q) is contained within the core region of the JD. This is consistent
with previous studies of ataxin-3 ﬁbril formation, which indicated
that protein aggregation initially involves self-association of the
JD [36,47], and also with computer predictions which indicated
the possibility of three main aggregation-prone regions of ataxin-
3 residing within the Josephin domain: namely residues 73–96,
159–167 and 144–154 [35,48].
Peptides resulting from proteolysis at all possible cleavage sites
within the ataxin-3 (14Q) C-terminal “tail” (residues 183–361)
were identiﬁed within ESI-MS spectra after 15 min  of trypsin expo-
sure (Figs. 4, 5 and Table 2). The majority of cleavage sites within
this region appear to be equally exposed, as peptides resulting from
cleavage at these sites are observed instantaneously. This suggests
strongly that the C-terminal region of ataxin-3 (14Q) possesses lit-
tle, if any, persistent tertiary structure that protects its potential
cleavage sites from trypsinolysis. Only two  species corresponding
to the presence of longer products within the C-terminal region,
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mino acid residues 286–361 and 296–361, were detected. These
eptides incorporate the polyQ region in addition to the third UIM.
owever, there is no trypsin cleavage site between Lys296 and
rg353 within the C-terminal region so further proteolysis within
his sequence is necessarily limited, and other peptides were also
etected indicating that the trypsin cleavage sites at Arg352 and
ys356 in this region were indeed accessible for proteolysis. Unfor-
unately, therefore, it is not possible from these data to assess
he compactness of the polyQ-containing region of ataxin-3 (14Q).
uture work involving the study of ataxin-3 constructs with dif-
erent proteases and/or polyQ stretches of different lengths will be
eeded to elucidate the conformational properties of this segment
f the polypeptide chain, and its dependence on the polyQ length,
n more detail.
. Conclusions
Here we have used ESI-IMS–MS and limited proteolysis exper-
ments to gain new information regarding the conformational
roperties of a polyQ-containing protein, ataxin-3 (14Q). These
xperiments show, for the ﬁrst time, that ataxin-3 (14Q) populates
imultaneously a wide range of conformational states in solution,
anging from highly compact to widely extended conformers. Lim-
ted proteolysis experiments have indicated that the C-terminal
tail” region of ataxin-3 (14Q) has little resistance to trypsin diges-
ion, consistent with this region being a dynamic, ﬂexible entity
ble to adopt a wide repertoire of conformational states. However,
he observation that the same tryptic peptides arise from the iso-
ated JD and the corresponding JD within ataxin-3 (14Q) following
imited trypsin proteolysis suggests that the C-terminal “tail” of
taxin-3 neither interacts with, nor shields, the JD from trypsinoly-
is. Furthermore, the dimerisation interface of ataxin-3 has been
hown to be likely contained within the JD core region encom-
assing residues 60–182. Together, the results highlight the power
f ESI-IMS–MS combined with limited proteolysis to examine the
onformational properties of this fascinating class of proteins. Fur-
her work, focussing on ataxin-3 variants with glutamine repeats
hat extend to, and beyond, the pathogenic length, and the interac-
ion of the protein with known modulators of ataxin-3 assembly,
ill cast new light into how and why these proteins assemble in
 polyQ length-dependent manner. The ability of ESI-IMS–MS to
nalyse complex samples with a range of solution conditions, and
o separate and structurally characterise lowly populated species
ithin heterogeneous mixtures, will be essential to unravel the
ssembly mechanisms of these important protein systems.
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